Medicure (MCUJF) Net Income towards Common Stockholders (2009 - 2026)

Medicure's Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at -$296057.5 for Q1 2026.

• On a quarterly basis, Net Income towards Common Stockholders fell 168.74% year-over-year to -$296057.5 in Q1 2026; TTM through Mar 2026 was -$8.8 million, a 2368.83% decrease from a year earlier, with the FY2025 full-year figure at -$5.1 million, down 569.33% from the prior year.
• Net Income towards Common Stockholders climbed to -$296057.5 in Q1 2026 per MCUJF's latest filing, from -$6.9 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $4.0 million in Q4 2022 and bottomed at -$6.9 million in Q4 2025.
• The 5-year median for Net Income towards Common Stockholders is $62658.2 (2023), against an average of -$182150.6.
• Biggest YoY gain for Net Income towards Common Stockholders was 1037.96% in 2025; the steepest drop was 1648.95% in 2025.
• Year by year, Net Income towards Common Stockholders stood at $4.0 million in 2022, then tumbled by 128.63% to -$1.1 million in 2023, then surged by 65.21% to -$395864.6 in 2024, then slumped by 1648.95% to -$6.9 million in 2025, then jumped by 95.72% to -$296057.5 in 2026.
• Per Business Quant, the three latest MCUJF Net Income towards Common Stockholders figures stand at -$296057.5 (Q1 2026), -$6.9 million (Q4 2025), and -$1.0 million (Q3 2025).